Tacrolimus Concentrations Measured in Excreted Bile in Liver Transplant Recipients The STABILE Study

Autor: Eric Bellissant, Laurent Sulpice, Jean-Marie Beaurepaire, Karim Boudjema, Alexandre Chebaro, C. Cusumano, Edouard Bardou-Jacquet, Camille Tron, Antoine Petitcollin, P. Houssel-Debry, Véronique Desfourneaux, Bernard Meunier, Marc Blondeau, Michel Rayar, Clara Locher, M. Lakehal, Florian Lemaitre, Marie Clémence Verdier, Christophe Camus

Publikováno v: Clinical Therapeutics
Clinical Therapeutics, Elsevier, 2018, 40 (12), pp.2088-2098. ⟨10.1016/j.clinthera.2018.10.015⟩
Clinical Therapeutics, 2018, 40 (12), pp.2088-2098. ⟨10.1016/j.clinthera.2018.10.015⟩

International audience; Purpose - Tacrolimus (TAC) is the main immunosuppressive drug in liver transplantation. Despite intensive therapeutic drug monitoring (TDM) that relies on whole blood trough concentration (TAC), patients still present with acu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329df28ba30813ab96457d53136a9519
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01975939